Herbalife Ltd. (HLF) Stock Price

HLFStock

$14.60+69.57%52W

Market Cap$1.53B

P/E6.70x

PEG Ratio0.61

Div yield—

Beta0.74

HLF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-22.32%

Price vs S&P 500 (4W)23.81%

PEG Ratio0.61

VGM Score61.52

P/E Ratio (Annual)6.70x

P/CF (Annual)4.59x

Book Value / Share (Quarterly)$1.23

P/TBV (Annual)33.04x

Revenue Growth (3Y)-1.08%

Cash Flow / Share (Quarterly)$3.08

Price vs S&P 500 (YTD)1.34%

Gross Margin (TTM)77.70%

Net Profit Margin (TTM)3.16%

EPS (TTM)$1.55

10-Day Avg Trading Volume1.51M

EPS Excl Extra (TTM)$1.55

Revenue Growth (5Y)-1.89%

EPS (Annual)$2.20

ROI (Annual)15.81%

Gross Margin (Annual)77.87%

Net Profit Margin (5Y Avg)5.26%

Cash / Share (Quarterly)$3.54

P/E Basic Excl Extra (TTM)9.32x

Revenue Growth QoQ (YoY)5.38%

EPS Growth (5Y)-4.47%

P/E Normalized (Annual)6.70x

ROA (Last FY)8.19%

Revenue Growth TTM (YoY)5.52%

EBITD / Share (TTM)$-5.80

ROE (5Y Avg)96.26%

Operating Margin (TTM)-14.08%

Cash Flow / Share (Annual)$2.45

P/B Ratio6.99x

P/B Ratio (Quarterly)29.02x

Net Income / Employee (Annual)$26,900

EV / Revenue (TTM)0.61x

Net Interest Coverage (TTM)2.25x

ROA (TTM)5.86%

EPS Growth QoQ (YoY)15.77%

EV / EBITDA (TTM)5.22x

EPS Incl Extra (Annual)$2.20

Current Ratio (Annual)1.13x

Quick Ratio (Quarterly)0.50x

3-Month Avg Trading Volume1.61M

52-Week Price Return69.57%

EV / Free Cash Flow (Annual)12.56x

P/E Incl Extra (TTM)9.32x

Revenue / Employee (TTM)$611,800

Tangible BV / Share (Quarterly)$1.19

P/S Ratio (Annual)0.30x

Asset Turnover (Annual)1.81x

52-Week High$20.40

Operating Margin (5Y Avg)9.42%

EPS Excl Extra (Annual)$2.20

CapEx CAGR (5Y)-6.41%

Tangible BV CAGR (5Y)41.71%

26-Week Price Return-12.42%

Quick Ratio (Annual)0.44x

13-Week Price Return21.77%

Total Debt / Equity (Annual)7.38x

Current Ratio (Quarterly)1.20x

Enterprise Value$3.18B

Revenue / Share Growth (5Y)3.37%

Asset Turnover (TTM)1.85x

Book Value / Share Growth (5Y)-6.72%

Revenue / Employee (Annual)$592,600

Inventory Turnover (Annual)2.26x

Pretax Margin (Annual)5.46%

Cash / Share (Annual)$3.42

3-Month Return Std Dev48.98%

Gross Margin (5Y Avg)77.66%

Net Income / Employee (TTM)$19,300

EBITDA CAGR (5Y)-4.26%

EBITDA Interim CAGR (5Y)-7.85%

ROE (Last FY)132.45%

Net Interest Coverage (Annual)2.16x

EPS Basic Excl Extra (Annual)$2.20

P/FCF (TTM)4.75x

Receivables Turnover (TTM)49.04x

EV / Free Cash Flow (TTM)9.85x

Total Debt / Equity (Quarterly)10.41x

EPS Incl Extra (TTM)$1.55

Receivables Turnover (Annual)62.66x

ROI (TTM)16.37%

P/S Ratio (TTM)0.29x

Pretax Margin (5Y Avg)6.14%

Revenue / Share (Annual)$48.62

Tangible BV / Share (Annual)$1.19

Forward P/E5.98x

Free OCF CAGR (5Y)-13.31%

Price vs S&P 500 (52W)54.04%

P/E Ratio (TTM)9.32x

EPS Growth TTM (YoY)-51.22%

Year-to-Date Return13.27%

5-Day Price Return7.27%

EPS Normalized (Annual)$2.20

ROA (5Y Avg)10.04%

Net Profit Margin (Annual)4.53%

Month-to-Date Return20.36%

Cash Flow / Share (TTM)$3.00

EBITD / Share (Annual)$5.60

EPS Growth (3Y)-11.96%

Operating Margin (Annual)9.55%

LT Debt / Equity (Annual)7.33x

P/CF (TTM)3.99x

ROI (5Y Avg)40.63%

P/E Excl Extra (TTM)9.32x

LT Debt / Equity (Quarterly)9.94x

EPS Basic Excl Extra (TTM)$1.55

P/TBV (Quarterly)33.04x

P/B Ratio (Annual)23.32x

Inventory Turnover (TTM)2.27x

Pretax Margin (TTM)4.10%

Book Value / Share (Annual)$1.05

Price vs S&P 500 (13W)19.08%

Net Margin Growth (5Y)-7.58%

Beta0.74x

P/FCF (Annual)6.05x

Revenue / Share (TTM)$49.77

ROE (TTM)170.70%

52-Week Low$7.56

vGradeB

gGradeD

mGradeA

vgmGradeB

HLF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.54	$0.51	-4.86%(-$0.03)
Q1 2026	May 6, 2026	$0.61	$0.64	+5.44%(+$0.03)
Q4 2025	Feb 18, 2026	$0.48	$0.45	-5.59%(-$0.03)
Q3 2025	Nov 5, 2025	$0.46	$0.50	+8.42%(+$0.04)
Q2 2025	Aug 6, 2025	$0.50	$0.59	+18.59%(+$0.09)

HLF Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Drug Wholesale(11)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
HLFHerbalife Ltd.	B	D	A	6.7x	170.7%	-14.1%	5.5%	$14.60
MCKMcKesson Corporation	D	B	B	24.6x	39.4%	1.6%	8.8%	$1004.84
CORCencora, Inc.	D	B	B	41.9x	106.4%	0.9%	5.1%	$340.92
CAHCardinal Health, Inc.	D	B	A	34.3x	37.2%	1.0%	14.2%	$254.06
NUSNuSkin Enterprises, Inc.	B	F	C	1.6x	-29.4%	-0.8%	-15.4%	$5.14
WGRXWellgistics Health, Inc. Common Stock	D	F	D	—	-1645.9%	-506.9%	-51.6%	$4.28
ZSTKZeroStack Corp. Common Stock	—	D	C	—	-382.3%	-595.2%	—	$4.00
ESYNEnerSyn Global Inc. Common Stock	—	—	C	—	—	—	—	$1.94
COSMCosmos Holdings Inc. Common Stock	D	B	C	—	-118.9%	-24.8%	33.8%	$0.33
HWHHWH International Inc. Common Stock	F	D	B	—	-103.9%	-716.1%	-68.5%	$1.98
MEDSDataMeds AI, Inc. Common Stock	D	D	D	—	-1645.9%	-1034.0%	-78.2%	$2.63
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares	—	F	F	—	—	—	—	$0.11

About Herbalife Ltd.

Herbalife operates a direct-selling health and wellness business in 95 markets, generating revenue primarily from weight management products such as meal replacements and protein shakes. The company also offers targeted nutrition, energy, and sports fitness products manufactured at facilities in the US and China, with support from third-party manufacturers. Herbalife serves customers across North America, Latin America, EMEA, Asia Pacific, and China.